Skip to main content
Premium Trial:

Request an Annual Quote

Cartagenia Adds Two New Customers to its Client List

Premium

Cartagenia has added Australia's Mater Hospitals, and the Life and Brain genetics lab, which is associated with University of Bonn, Germany and Groningen University Medical Center in the Netherlands to its client list.

Both institutions have licensed Cartagenia's BenchLab NGS, the company's software and database solution for next-generation sequence variant analysis, interpretation, and reporting.

The financial details of the agreements were not disclosed.

Cartagenia's customer base includes the Birmingham Women's Hospital NHS Foundation Trust, which licensed the company's software for use in its West Midlands Regional Genetics Laboratory (BI 4/12/2013), and Greenwood Genetic Center, a non-profit institute that provides clinical genetic services and diagnostic laboratory testing (BI 3/22/2013).

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.